Screener > Sectoral / Thematic > BAJAJ FINSERV HEALTHCARE FUND

BAJAJ FINSERV HEALTHCARE FUND - REGULAR - GROWTH

Compare with Peers →
AMC: Bajaj Finserv Mutual Fund • Category: Sectoral / Thematic • NAV: Rs 12.139 (2026-11-11) • Rank: #102 in category (#428 overall) • Index Proxy: Nifty 500
🛡️ Lower Volatility 🦺 Crash Buffer ⭐ Consistent Alpha 🚀 High Bull Capture
Information only. Past performance does not guarantee future returns. Check the scheme documents and consult a qualified professional before investing.

💡 Why Pick This Fund? Quantitative Strengths & Watch-outs

🟢 Key Strengths
  • Strong capital defense: downside capture of 55% limits losses during market corrections.
  • Generated +19.0% annualized alpha (excess return) over its benchmark.
🟡 Things to Keep in Mind
  • Limited historical track record under 3 years; long-term cycle performance is still evolving.
₹84₹93₹103₹113₹123Dec '24Dec '25Nov '26
BAJAJ FINSERV HEALTHCARE FUND
Proxy (Nifty 500)

Key Statistics vs Category Median

Fund Size
Rs 443 cr
Category: Rs 804 cr (small)
Total Expense (TER)
2.59%
Category Median: 2.52%
Base Expense (BER)
2.09%
Excludes levies & brokerage
Sharpe Ratio
1.22
Category Median: 0.34
Beta
0.60
Category Median: 0.97
Alpha
+19.01%
Category Median: +1.89%
Standard Deviation
13.59%
Category Median: 16.05%
MFIQ Score
7.8/10
Good
Solid risk-adjusted returns and competitive cost profile within its category.
Returns (30%) 9.5/10
1Y return 24.0% against category median 3.9% (+20.1 points).
Risk Management (30%) 8.7/10
Sharpe ratio 1.22 (cat median 0.34), downside capture 54.9%, max fall -15.9%.
Consistency (20%) -/10
Under 3 years of consistency track record.
Cost Efficiency (20%) 4.1/10
Total expense ratio 2.59% vs category median 2.52% (+0.07% points).
Ranked #102 of 221 in Sectoral / Thematic. Percentile standing measured against category cohort.

Trailing Returns Comparison

Period Fund Return Category Median Difference
1 Month +8.31% +6.32% +1.99%
3 Months +3.07% -0.20% +3.27%
6 Months +17.04% +5.98% +11.06%
1 Year +24.03% +3.90% +20.13%
Since Inception +10.49% - -

Calendar Year Returns

Year Fund Category Median Gap
2026 +25.99% +4.03% +21.96%
2025 -4.58% +1.43% -6.01%

Daily Rolling Returns Summary

Rolling Window Minimum Average Median Maximum % Positive % Beating Proxy
1-Year Rolling -5.81% +10.26% +10.83% +24.56% 85.5% 68.2%

Risk Profile & Deepest Drawdowns

Sortino Ratio
1.82
Category: 0.46
R-Squared
0.431
Correlation with Proxy
Upside Capture
142.4%
Monthly return ratio
Downside Capture
54.9%
Lower is better

Deepest Market Corrections (Depth >= 10%)

Peak Date Trough Date Fall Depth Months to Bottom Recovery Period
2025-01-02 2025-02-28 -15.9% 2 months 14 months
2026-09-08 2026-10-23 -11.1% 1 months 1 months

Portfolio & Asset Allocation

Statutory Asset Allocation Mandate (SEBI / SID)

Instrument Category Permitted Allocation Range
Equity and Equity Related Securities of pharma, healthcare and allied companies 80% - 100%, Equities and Equity related securities of other than pharma, healthcare and allied companies - 0% - 20% Money market instruments*, other liquid instruments, Units of InvITs, Units of Gold ETFs and Silver ETFs and units of Liquid, Overnight and Money Market Mutual Fund - 0% - 20% *Money market instruments will include commercial papers,commercial bills, Triparty REPO, Reverse Repo and equivalent and any other like instruments as specified by SEBI and Reserve Bank of India from time to time.

Investment Objective & Strategy

The objective of the Scheme is to generate long term capital appreciation by predominantly investing in equity and equity related securities of pharma, healthcare and allied companies. However, there is no assurance that the investment objective of the Scheme will be achieved.

ℹ️ Detailed monthly stock-level holdings for this scheme are updated periodically from asset management company statutory disclosures.

Fund Size Position

Currently managing Rs 443 cr (AMFI Daily Fund AUM as of 2026-11-11). Positioned as small relative to Sectoral / Thematic schemes.

Too Small Small Comfortable Stretched Strained

Fund Management

Bharat Hegde
Sorbh Gupta
Managing scheme since 2026-09-28
0.1 yrs tenure
Siddharth Chaudhary

Cost & Capital Gains Taxation

From April 2026 the total expense ratio includes brokerage, transaction costs and statutory levies on top of the base fee.

Applicable Tax Structure

Equity-oriented schemes: 20% short-term capital gains tax if sold within 12 months; 12.5% long-term capital gains tax on gains exceeding ₹1.25 lakh per financial year when held for more than 12 months.

Tax rules as of 23 July 2024. Verify before investing.

Closest Sectoral / Thematic Peers by Rank

Scheme Score 3Y Return Expense Downside Fund Size Compare
PGIM India Healthcare Fund 7.9 - 2.65% 63.6% Rs 152 cr Compare →
WhiteOak Capital Pharma and Heathcare Fund 7.7 - 2.70% 44.1% Rs 1,022 cr Compare →
Kotak Healthcare Fund 7.5 - 2.49% 35.1% Rs 928 cr Compare →
SBI Automotive Opportunities Fund 8.0 - 1.98% 99.8% Rs 6,374 cr Compare →
Samco Flexi Cap Fund 0.8 -4.37% 3.17% 150.0% Rs 235 cr Compare →

Frequently Asked Questions about BAJAJ FINSERV HEALTHCARE FUND

What is the expense ratio of BAJAJ FINSERV HEALTHCARE FUND?

BAJAJ FINSERV HEALTHCARE FUND has a total expense ratio (TER) of 2.59% with a base expense ratio of 2.09%, compared to the Sectoral / Thematic category median of 2.52%.

Who manages BAJAJ FINSERV HEALTHCARE FUND?

BAJAJ FINSERV HEALTHCARE FUND is managed by Bharat Hegde.

What are the historical returns of BAJAJ FINSERV HEALTHCARE FUND?

BAJAJ FINSERV HEALTHCARE FUND has a 1-year return of +24.03%.

How large is BAJAJ FINSERV HEALTHCARE FUND?

BAJAJ FINSERV HEALTHCARE FUND manages assets of Rs 443 cr, placing it in the 'small' size band relative to Sectoral / Thematic peers.

How is BAJAJ FINSERV HEALTHCARE FUND scored on MFIQ?

BAJAJ FINSERV HEALTHCARE FUND holds an MFIQ Score of 7.8/10 (Good), based on a category percentile composite across returns, risk, consistency, and cost.

How risky is BAJAJ FINSERV HEALTHCARE FUND?

BAJAJ FINSERV HEALTHCARE FUND has an official SEBI riskometer rating of Very High. Over the analyzed period, its annualized standard deviation is 13.59% with a maximum historical drawdown of -15.91%.